- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BMS 188667 (Abatacept)
Total 3369 results
-
Bristol-Myers SquibbCompletedHepatic ImpairmentUnited States
-
Janssen Research & Development, LLCCompleted
-
Ronald LevyBristol-Myers SquibbCompletedAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Extracranial Solid NeoplasmUnited States
-
Bristol-Myers SquibbCompletedRheumatoid Arthritis | Systemic Lupus Erythematosus | Autoimmune Disorder | Primary Sjögren's SyndromeUnited States, Argentina, Belgium, France, Germany, Mexico, Poland, Spain, Netherlands, United Kingdom
-
M.D. Anderson Cancer CenterActive, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Carcinoma in the Liver | Metastatic Carcinoma in the Lung | Metastatic Malignant Neoplasm in the Thoracic CavityUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited Kingdom, Netherlands
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerItaly, Australia, United States, Spain, Romania, Argentina, Canada, Chile, Finland, Germany, Poland
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbCompletedMelanoma | Skin CancerUnited States, Canada, Netherlands, Spain, Australia, Italy, Japan, Germany, Ireland, United Kingdom, Czechia, Switzerland, Poland, France, Greece, New Zealand
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Janssen Research & Development, LLCBristol-Myers SquibbRecruitingAcute Coronary SyndromeTaiwan, Korea, Republic of, United States, Italy, South Africa, Belgium, Argentina, Israel, Malaysia, Romania, Serbia, China, Australia, Netherlands, United Kingdom, Denmark, Czechia, Hungary, Japan, France, Canada, Bulgaria, Spain, T... and more
-
Janssen Research & Development, LLCBristol Myers Squibb Company (BMS)RecruitingIschemic Stroke; Ischemic Attack, TransientItaly, United States, Hong Kong, Japan, Taiwan, Korea, Republic of, Israel, United Kingdom, Argentina, Belgium, New Zealand, Canada, Germany, Denmark, Mexico, Croatia, France, Australia, Brazil, China, Czechia, Hungary, Netherlands, S... and more
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
-
The Methodist Hospital Research InstituteRecruiting
-
Bristol-Myers SquibbWithdrawnMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelogenous Leukemia
-
R-PharmCompletedMetastatic Pancreatic CancerUnited States
-
Universitaire Ziekenhuizen KU LeuvenZiekenhuis Netwerk Antwerpen (ZNA)Completed
-
St George's, University of LondonCompletedRheumatoid ArthritisUnited Kingdom
-
Bristol-Myers SquibbClovis Oncology, Inc.CompletedAdvanced Gastric CancerUnited States, Israel, Netherlands, Canada, Italy, Australia, Germany, Singapore, Switzerland
-
CelgeneActive, not recruitingEosinophilic GastroenteritisJapan
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbTerminatedAdvanced Solid MalignanciesUnited States, Canada
-
Thomas Jefferson UniversityBristol-Myers SquibbActive, not recruitingLarynx | Squamous Cell Carcinoma | Lip | Oral Cavity Squamous Cell Carcinoma | PharynxUnited States
-
Bristol-Myers SquibbMedarexCompleted
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedLupus Erythematosus, Systemic | Lupus NephritisUnited States, Mexico
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
University of ChicagoBristol-Myers SquibbCompletedCancerUnited States
-
Bristol-Myers SquibbRecruitingAlzheimer Disease, Early OnsetUnited States, Australia, Belgium, Canada, Denmark, France, Japan, Korea, Republic of, Netherlands, Poland, Singapore, Spain, Sweden, United Kingdom
-
CelgeneRecruitingEosinophilic EsophagitisUnited States
-
The University of Hong KongNot yet recruiting
-
Bristol-Myers SquibbWithdrawnAdvanced Solid TumorsSpain
-
Bristol-Myers SquibbCompletedModerate Liver Impairment | Severe Liver ImpairmentUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedCongestive Heart Failure | Liver Dysfunction | Heart Decompensation | Cardiac Failure | Liver Insufficiency | Myocardial Failure | Hepatic FailureHungary, Poland
-
Bristol-Myers SquibbCompletedChronic Hepatitis CFrance, United States, Puerto Rico
-
Bristol-Myers SquibbCompletedLupusTaiwan, United States, Canada, Italy, Mexico, South Africa, Korea, Republic of, Japan, France, Spain, Argentina, Hungary, Colombia, Peru, Poland, Puerto Rico, Romania, Brazil, Chile, Germany, Lebanon, Netherlands, Russian Federation
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France
-
Timothy Morgan, MDBristol-Myers Squibb; National Cancer Institute (NCI); VA Long Beach Healthcare...Completed
-
AbbVieCompletedRheumatoid Arthritis (RA)United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Korea, Republic of, Latvia, Mexico, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Romania, Russian... and more
-
Biohaven Pharmaceuticals, Inc.Active, not recruitingNeuromuscular Diseases | Spinal Muscular Atrophy | SMAUnited States, Netherlands, United Kingdom, Spain, Czechia, Belgium, Germany, Italy, Poland
-
Bristol-Myers SquibbCompletedHealthy ParticipantsChina
-
RWTH Aachen UniversityWithdrawnCirrhosis of the Liver | Re-stenosis
-
Dan ZandbergBristol-Myers SquibbActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
Bristol-Myers SquibbActive, not recruiting